T1	PROC 205 212	tratado
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	PROC 60 73	inmunoterapia
#2	AnnotatorNotes T2	C0021083; Immunotherapy; Therapeutic or Preventive Procedure
T3	PROC 401 408	tratado
#3	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	CHEM 105 114	nivolumab
#4	AnnotatorNotes T4	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T5	CHEM 124 133	nivolumab
#5	AnnotatorNotes T5	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T6	DISO 156 164	melanoma
#6	AnnotatorNotes T6	C0025202; melanoma; Neoplastic Process
T7	PROC 235 272	Estudio fase 3, aleatorizado, abierto
#7	AnnotatorNotes T7	C0282461; Phase 3 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C1709323; Open Label Study; Research Activity 
T8	CHEM 305 314	nivolumab
#8	AnnotatorNotes T8	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T9	CHEM 324 333	nivolumab
#9	AnnotatorNotes T9	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T10	DISO 351 359	melanoma
#10	AnnotatorNotes T10	C0025202; melanoma; Neoplastic Process
T11	DISO 432 440	Melanoma
#11	AnnotatorNotes T11	C0025202; melanoma; Neoplastic Process
T12	DISO 503 511	Melanoma
#12	AnnotatorNotes T12	C0025202; melanoma; Neoplastic Process
T13	PROC 469 476	tratado
#13	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	DISO 768 776	Melanoma
#14	AnnotatorNotes T14	C0025202; melanoma; Neoplastic Process
T15	PROC 864 875	tratamiento
#15	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	PROC 901 922	tratamiento sistémico
T17	DISO 940 948	melanoma
#16	AnnotatorNotes T17	C0025202; melanoma; Neoplastic Process
T18	PROC 991 1012	tratamiento adyuvante
#17	AnnotatorNotes T18	C0677850; Adjuvant therapy; Therapeutic or Preventive ProcedureC0677850; Adjuvant therapy; Therapeutic or Preventive Procedure [Positive entity (double negation context)]
T19	PROC 541 548	tratado
#18	AnnotatorNotes T19	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T20	DISO 1049 1070	Metástasis cerebrales
#19	AnnotatorNotes T20	C0220650; Metastatic malignant neoplasm to brain; Neoplastic Process | C0555278; Cerebral metastasis; Neoplastic Process
T21	DISO 1081 1106	metástasis leptomeníngeas
#20	AnnotatorNotes T21	C1704231; Metastatic Malignant Neoplasm to the Leptomeninges; Neoplastic Process
T22	DISO 1111 1125	Melanoma uveal
#21	AnnotatorNotes T22	C0346373; Malignant melanoma of iris; Neoplastic Process
T23	DISO 1142 1163	enfermedad autoinmune
#22	AnnotatorNotes T23	C0004364; Autoimmune Diseases; Disease or Syndrome
T24	DISO 178 189	metastásico
#23	AnnotatorNotes T24	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T25	DISO 374 385	metastásico
#24	AnnotatorNotes T25	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T26	DISO 454 465	metastásico
#25	AnnotatorNotes T26	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T27	DISO 526 537	metastásico
#26	AnnotatorNotes T27	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T28	DISO 963 974	metastásico
#27	AnnotatorNotes T28	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T29	ANAT 1060 1070	cerebrales
#28	AnnotatorNotes T29	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T30	ANAT 1092 1106	leptomeníngeas
#29	AnnotatorNotes T30	C0228126; Leptomeninges; Body Part, Organ, or Organ Component | C1284563; Entire leptomeninges; Body Part, Organ, or Organ Component
T31	ANAT 1120 1125	uveal
#30	AnnotatorNotes T31	C0042160; Uvea; Body Part, Organ, or Organ Component
T32	CHEM 94 102	NKTR-214
#31	AnnotatorNotes T32	C4309517; NKTR-214; Amino Acid, Peptide, or Protein · Biologically Active Substance
T33	CHEM 277 285	NKTR-214
#32	AnnotatorNotes T33	C4309517; NKTR-214; Amino Acid, Peptide, or Protein · Biologically Active Substance
T34	Date 13 17	2018
T35	LIVB 142 151	pacientes
#33	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	Neg_cue 202 204	no
T37	LIVB 337 346	pacientes
#34	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	Neg_cue 398 400	no
T39	Neg_cue 466 468	no
T40	Neg_cue 538 540	no
T42	LIVB 647 654	adultos
#35	AnnotatorNotes T42	C0001675; Adult; Age Group
T43	Age 658 671	18 años o más
T45	Age 752 762	12-17 años
T47	LIVB 850 859	Pacientes
#36	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	Neg_cue 860 863	sin
T49	Neg_cue 894 900	ningún
T51	LIVB 1128 1137	Pacientes
#37	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	Spec_cue 1183 1193	sospechada
T41	LIVB 728 735	menores
#38	AnnotatorNotes T41	C0026193; Minor (person); Population Group
T44	PROC 577 593	Estado funcional
#39	AnnotatorNotes T44	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T46	PROC 688 704	estado funcional
#40	AnnotatorNotes T46	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T50	PROC 788 804	histológicamente
#41	AnnotatorNotes T50	C0344441; Histology Procedure; Laboratory Procedure
A1	Assertion T1 Negated
A2	Assertion T3 Negated
A3	Assertion T13 Negated
A4	Assertion T19 Negated
A5	Population_data T42 Age
A6	Assertion T15 Negated
A7	Assertion T16 Negated
A8	Assertion T23 Speculated
A9	Status T1 History_of
A10	Status T3 History_of
A11	Status T13 History_of
A12	Status T19 History_of
A13	Status T15 History_of
A14	Status T16 History_of
A15	Status T18 History_of
A16	Status T23 History_of
R1	Used_for Arg1:T32 Arg2:T2	
R2	Combined_with Arg1:T32 Arg2:T4	
R3	Used_for Arg1:T5 Arg2:T2	
T53	Quantifier_or_Qualifier 134 138	solo
R4	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T53	
R5	Combined_with Arg1:T33 Arg2:T8	
R6	Experiences Arg1:T37 Arg2:T9	
R7	Experiences Arg1:T35 Arg2:T2	
R8	Experiences Arg1:T35 Arg2:T6	
R9	Experiences Arg1:T35 Arg2:T24	
R10	Negation Arg1:T36 Arg2:T1	
R11	Experiences Arg1:T35 Arg2:T1	
T54	Observation 165 175	inoperable
#42	AnnotatorNotes T54	C4039777; Tumor surgically unresectable; Finding
R13	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T54	
T55	Observation 360 371	irresecable
#43	AnnotatorNotes T55	C4039777; Tumor surgically unresectable; Finding
R14	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T55	
R15	Experiences Arg1:T37 Arg2:T10	
R17	Experiences Arg1:T37 Arg2:T25	
R18	Negation Arg1:T38 Arg2:T3	
T56	Observation 441 451	inoperable
#44	AnnotatorNotes T56	C4039777; Tumor surgically unresectable; Finding
R19	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T56	
R20	Before Arg1:T11 Arg2:T26	
R21	Before Arg1:T6 Arg2:T24	
R22	Experiences Arg1:T37 Arg2:T33	
R23	Experiences Arg1:T37 Arg2:T3	
T57	Observation 512 523	irresecable
#45	AnnotatorNotes T57	C4039777; Tumor surgically unresectable; Finding
R24	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T57	
R25	Before Arg1:T12 Arg2:T27	
R26	Negation Arg1:T40 Arg2:T19	
R27	Negation Arg1:T39 Arg2:T13	
R28	Negation Arg1:T49 Arg2:T16	
R29	Negation Arg1:T48 Arg2:T15	
R30	Experiences Arg1:T47 Arg2:T15	
R31	Experiences Arg1:T47 Arg2:T16	
T58	Observation 949 960	irresecable
#46	AnnotatorNotes T58	C4039777; Tumor surgically unresectable; Finding
R32	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T58	
R33	Before Arg1:T17 Arg2:T28	
T59	Observation 822 833	irresecable
#47	AnnotatorNotes T59	C4039777; Tumor surgically unresectable; Finding
T60	Quantifier_or_Qualifier 809 820	estadio III
R35	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T60	
R36	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T59	
T61	Quantifier_or_Qualifier 837 847	estadio IV
R37	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T61	
R38	Experiences Arg1:T47 Arg2:T18	
R39	Experiences Arg1:T47 Arg2:T17	
R41	Experiences Arg1:T47 Arg2:T28	
R42	Location_of Arg1:T29 Arg2:T20	
R43	Location_of Arg1:T30 Arg2:T21	
T62	Quantifier_or_Qualifier 1071 1078	activas
#48	AnnotatorNotes T62	C0679217; Active State; Idea or Concept
R44	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T62	
R45	Experiences Arg1:T51 Arg2:T23	
R46	Location_of Arg1:T31 Arg2:T22	
T63	Quantifier_or_Qualifier 1164 1170	activa
#49	AnnotatorNotes T63	C0679217; Active State; Idea or Concept
R47	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T63	
R48	Speculation Arg1:T52 Arg2:T23	
T64	CONC 598 632	Eastern Cooperative Oncology Group
#50	AnnotatorNotes T64	C1520224; ECOG performance status; Intellectual Product
T65	CONC 634 638	ECOG
#51	AnnotatorNotes T65	C1520224; ECOG performance status; Intellectual Product
R49	Used_for Arg1:T65 Arg2:T44	
R50	Used_for Arg1:T64 Arg2:T44	
T66	Result_or_Value 640 645	</= 1
R51	Has_Age Arg1:T42 Arg2:T43	
R52	Experiences Arg1:T42 Arg2:T44	
R53	Has_Result_or_Value Arg1:T65 Arg2:T66	
R54	Has_Result_or_Value Arg1:T64 Arg2:T66	
T67	CONC 708 714	Lansky
#52	AnnotatorNotes T67	C1522275; Lansky Play-Performance Status; Intellectual Product
R55	Used_for Arg1:T67 Arg2:T46	
T68	Result_or_Value 716 723	>/= 80%
R56	Has_Result_or_Value Arg1:T67 Arg2:T68	
R57	Has_Age Arg1:T41 Arg2:T45	
R58	Experiences Arg1:T41 Arg2:T46	
R59	Before Arg1:T10 Arg2:T25	
#53	AnnotatorNotes T16	C1515119; Systemic Therapy; Therapeutic or Preventive Procedure
#54	AnnotatorNotes T53	C0205171; Singular; Quantitative Concept
A17	Experiencer T51 Patient
A18	Experiencer T47 Patient
A19	Experiencer T41 Patient
A20	Experiencer T42 Patient
A21	Experiencer T35 Patient
A22	Experiencer T37 Patient
